212 related articles for article (PubMed ID: 31183946)
1. Psychological correlates of adherence to photoprotection in a rare disease: International survey of people with Xeroderma Pigmentosum.
Walburn J; Canfield M; Norton S; Sainsbury K; Araújo-Soares V; Foster L; Berneburg M; Sarasin A; Morrison-Bowen N; Sniehotta FF; Sarkany R; Weinman J
Br J Health Psychol; 2019 Sep; 24(3):668-686. PubMed ID: 31183946
[TBL] [Abstract][Full Text] [Related]
2. The influence of perceived medical risks and psychosocial concerns on photoprotection behaviours among adults with xeroderma pigmentosum: a qualitative interview study in the UK.
Morgan M; Anderson R; Walburn J; Weinman J; Sarkany R
BMJ Open; 2019 Feb; 9(2):e024445. PubMed ID: 30782905
[TBL] [Abstract][Full Text] [Related]
3. An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods.
Walburn J; Sarkany R; Norton S; Foster L; Morgan M; Sainsbury K; Araújo-Soares V; Anderson R; Garrood I; Heydenreich J; Sniehotta FF; Vieira R; Wulf HC; Weinman J
BMJ Open; 2017 Aug; 7(8):e018364. PubMed ID: 28827277
[TBL] [Abstract][Full Text] [Related]
4. Identifying the psychosocial predictors of ultraviolet exposure to the face in patients with xeroderma pigmentosum: a study of the behavioural factors affecting clinical outcomes in this genetic disease.
Sarkany R; Norton S; Canfield M; Morgan M; Foster L; Sainsbury K; Araujo-Soares V; Wulf HC; Weinman J; Walburn J
J Med Genet; 2022 Nov; 59(11):1095-1103. PubMed ID: 35393336
[TBL] [Abstract][Full Text] [Related]
5. Facial photoprotection in xeroderma pigmentosum (XP) patients: Validation of a new self-reported questionnaire of adherence.
Canfield M; Norton S; Walburn J; Morrison-Bowen N; Sainsbury K; Araujo-Soares V; Sarkany R; Weinman J
Photodermatol Photoimmunol Photomed; 2020 Mar; 36(2):118-125. PubMed ID: 31596975
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet radiation exposure to the face in patients with xeroderma pigmentosum and healthy controls: applying a novel methodology to define photoprotection behaviour.
Sarkany RPE; Canfield M; Morgan M; Foster L; Johnstone K; Sainsbury K; Araujo-Soares V; Wulf HC; Weinman J; Walburn J; Norton S
Br J Dermatol; 2022 Apr; 186(4):713-720. PubMed ID: 34783007
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a personalised adherence intervention to improve photoprotection in adults with Xeroderma Pigmentosum (XP): protocol for the trial of XPAND.
Walburn J; Norton S; Sarkany R; Sainsbury K; Araújo-Soares V; Morgan M; Canfield M; Foster L; Heydenreich J; McCrone P; Mander A; Sniehotta FF; Wulf HC; Weinman J
BMJ Open; 2019 Jul; 9(7):e028577. PubMed ID: 31320353
[TBL] [Abstract][Full Text] [Related]
8. Understanding and predicting a complex behavior using n-of-1 methods: Photoprotection in xeroderma pigmentosum.
Sainsbury K; Vieira R; Walburn J; Sniehotta FF; Sarkany R; Weinman J; Araujo-Soares V
Health Psychol; 2018 Dec; 37(12):1145-1158. PubMed ID: 30221970
[TBL] [Abstract][Full Text] [Related]
9. Approaches to Photoprotection and Normalization in Highly Adherent Families of Children With Xeroderma Pigmentosum in the United Kingdom.
Anderson R; Walburn J; Morgan M
Qual Health Res; 2020 Jul; 30(8):1275-1286. PubMed ID: 30741094
[TBL] [Abstract][Full Text] [Related]
10. Forms, interactions, and responses to social support: A qualitative study of support and adherence to photoprotection amongst patients with Xeroderma Pigmentosum.
Walburn J; Anderson R; Morgan M
Br J Health Psychol; 2020 Feb; 25(1):89-106. PubMed ID: 31756279
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma pigmentosum clinical practice guidelines.
Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
[TBL] [Abstract][Full Text] [Related]
12. Acceptability and influence of a complex personalized intervention on changes in photoprotection behaviours among people with xeroderma pigmentosum.
Walburn J; Foster L; Araújo-Soares V; Sarkany R; Weinman J; Sainsbury K; Morgan M
Br J Health Psychol; 2023 Nov; 28(4):1113-1131. PubMed ID: 37414737
[TBL] [Abstract][Full Text] [Related]
13. Why? What? How? Using an Intervention Mapping approach to develop a personalised intervention to improve adherence to photoprotection in patients with Xeroderma Pigmentosum.
Walburn J; Sainsbury K; Foster L; Weinman J; Morgan M; Norton S; Canfield M; Chadwick P; Sarkany B; Araújo-Soares V
Health Psychol Behav Med; 2020 Oct; 8(1):475-500. PubMed ID: 34040882
[No Abstract] [Full Text] [Related]
14. Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients.
Tamura D; DiGiovanna JJ; Khan SG; Kraemer KH
Photodermatol Photoimmunol Photomed; 2014; 30(2-3):146-52. PubMed ID: 24417420
[TBL] [Abstract][Full Text] [Related]
15. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
16. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of vitamin D deficiency in patients with xeroderma pigmetosum-A under strict sun protection.
Kuwabara A; Tsugawa N; Tanaka K; Uejima Y; Ogawa J; Otao N; Yamada N; Masaki T; Nishigori C; Moriwaki S; Okano T
Eur J Clin Nutr; 2015 Jun; 69(6):693-6. PubMed ID: 25669318
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient Care.
Nishigori C; Nakano E; Masaki T; Ono R; Takeuchi S; Tsujimoto M; Ueda T
Photochem Photobiol; 2019 Jan; 95(1):140-153. PubMed ID: 30565713
[TBL] [Abstract][Full Text] [Related]
19. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
20. Skin cancers in patients of skin phototype V or VI with xeroderma pigmentosum type C (XP-C): A retrospective study.
Ventéjou S; Bagny K; Waldmeyer J; Cartault F; Machet L; Osdoit S
Ann Dermatol Venereol; 2019 Mar; 146(3):192-203. PubMed ID: 30853323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
